77 results
Page 3 of 4
8-K
EX-2.1
oanvmwmk ksx
22 Jun 23
Talaris Therapeutics and Tourmaline Bio Announce Merger Agreement
9:10am
8-K
EX-99.1
vpm4onu
22 Jun 23
Talaris Therapeutics and Tourmaline Bio Announce Merger Agreement
9:10am
8-K
EX-99.2
5ju1zbr8htl0n55cav
22 Jun 23
Talaris Therapeutics and Tourmaline Bio Announce Merger Agreement
9:10am
8-K
EX-99.1
h9y4ju0lmkg2z6653
30 May 23
Talaris Therapeutics Announces Leadership Transition
4:51pm
8-K
wze3r0dzft8s
14 Apr 23
Cost Associated with Exit or Disposal Activities
5:20pm
8-K
EX-99.1
6d3lzuj
10 Nov 22
Talaris Therapeutics Announces Third Quarter Financial Results and Corporate Update
7:12am
8-K
EX-99.1
vb1im7b69q7p
20 Oct 22
Talaris Therapeutics Provides Update on FREEDOM-1 Phase 3 Clinical Trial
7:12am
8-K
EX-99.1
fe79kuw
15 Aug 22
Talaris Therapeutics Announces Second Quarter Financial Results and Corporate Update
7:13am
8-K
EX-99.1
zxytj
30 Jun 22
Other Events
4:54pm
8-K
3wxfdrwo08wvna
30 Jun 22
Other Events
4:54pm
8-K
EX-99.1
ikwh a7dpb60u8f
17 May 22
Talaris Therapeutics Announces Changes to Board of Directors
8:29am
8-K
EX-99.1
osl9r32cre1v73
12 May 22
Talaris Therapeutics Announces First Quarter Financial Results and Corporate Update
4:07pm
10-K
bs0b1hwg70ljhiy
17 Mar 22
Annual report
4:31pm
8-K
EX-99.1
r0v14l
17 Mar 22
Talaris Therapeutics Announces Fourth Quarter and Year-End Financial Results and Provides Business Update
4:13pm